Literature DB >> 19426225

Immunoregulation by tumor necrosis factor superfamily member LIGHT.

Yugang Wang1, Mingzhao Zhu, Mendy Miller, Yang-Xin Fu.   

Abstract

SUMMARY: LIGHT (homologous to lymphotoxins, inducible expression, competes with herpesvirus glycoprotein D for herpesvirus entry mediator, a receptor expressed on T lymphocytes) is a member of the tumor necrosis factor superfamily that contributes to the regulation of immune responses. LIGHT can influence T-cell activation both directly and indirectly by engagement of various receptors that are expressed on T cells and on other types of cells. LIGHT, LIGHT receptors, and their related binding partners constitute a complicated molecular network in the regulation of various processes. The molecular cross-talk among LIGHT and its related molecules presents challenges and opportunities for us to study and to understand the full extent of the LIGHT function. Previous research from genetic and functional studies has demonstrated that dysregulation of LIGHT expression can result in the disturbance of T-cell homeostasis and activation, changing the ability of self-tolerance and of the control of infection. Meanwhile, blockade of LIGHT activity can ameliorate the severity of various T-cell-mediated diseases. These observations indicate the importance of LIGHT and its involvement in many physiological and pathological conditions. Understanding LIGHT interactions offers promising new therapeutic strategies that target LIGHT-engaged pathways to fight against cancer and various infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19426225      PMCID: PMC4634935          DOI: 10.1111/j.1600-065X.2009.00762.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  80 in total

1.  LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response.

Authors:  K Tamada; K Shimozaki; A I Chapoval; Y Zhai; J Su; S F Chen; S L Hsieh; S Nagata; J Ni; L Chen
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

Review 2.  Thematic review series: the immune system and atherogenesis. Immune function in atherogenesis.

Authors:  Godfrey S Getz
Journal:  J Lipid Res       Date:  2004-11-16       Impact factor: 5.922

3.  Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction.

Authors:  R B Shaikh; S Santee; S W Granger; K Butrovich; T Cheung; M Kronenberg; H Cheroutre; C F Ware
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

4.  TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator.

Authors:  Thi Sau Migone; Jun Zhang; Xia Luo; Li Zhuang; Cecil Chen; Bugen Hu; June S Hong; James W Perry; Su Fang Chen; Joe X H Zhou; Yun Hee Cho; Stephen Ullrich; Palanisamy Kanakaraj; Jeffrey Carrell; Ernest Boyd; Henrik S Olsen; Gang Hu; Laurie Pukac; Ding Liu; Jian Ni; Sunghee Kim; Reiner Gentz; Ping Feng; Paul A Moore; Steve M Ruben; Ping Wei
Journal:  Immunity       Date:  2002-03       Impact factor: 31.745

5.  Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function.

Authors:  Jeffrey L Browning; Norm Allaire; Apinya Ngam-Ek; Evangelia Notidis; Jane Hunt; Steven Perrin; Roy A Fava
Journal:  Immunity       Date:  2005-11       Impact factor: 31.745

6.  The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells.

Authors:  I A Rooney; K D Butrovich; A A Glass; S Borboroglu; C A Benedict; J C Whitbeck; G H Cohen; R J Eisenberg; C F Ware
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

7.  ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5.

Authors:  H Hsu; I Solovyev; A Colombero; R Elliott; M Kelley; W J Boyle
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

8.  B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.

Authors:  John R Sedy; Maya Gavrieli; Karen G Potter; Michelle A Hurchla; R Coleman Lindsley; Kai Hildner; Stefanie Scheu; Klaus Pfeffer; Carl F Ware; Theresa L Murphy; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2004-11-28       Impact factor: 25.606

Review 9.  The B7 family and cancer therapy: costimulation and coinhibition.

Authors:  Xingxing Zang; James P Allison
Journal:  Clin Cancer Res       Date:  2007-09-15       Impact factor: 12.531

10.  Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis.

Authors:  Stefanie Scheu; Judith Alferink; Tobias Pötzel; Winfried Barchet; Ulrich Kalinke; Klaus Pfeffer
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

View more
  17 in total

1.  Signal regulatory protein α regulates the homeostasis of T lymphocytes in the spleen.

Authors:  Miho Sato-Hashimoto; Yasuyuki Saito; Hiroshi Ohnishi; Hiroko Iwamura; Yoshitake Kanazawa; Tetsuya Kaneko; Shinya Kusakari; Takenori Kotani; Munemasa Mori; Yoji Murata; Hideki Okazawa; Carl F Ware; Per-Arne Oldenborg; Yoshihisa Nojima; Takashi Matozaki
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

Review 2.  Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.

Authors:  Haidong Tang; Mingzhao Zhu; Jian Qiao; Yang-Xin Fu
Journal:  Cell Mol Immunol       Date:  2017-04-17       Impact factor: 11.530

Review 3.  Immunotherapy and tumor microenvironment.

Authors:  Haidong Tang; Jian Qiao; Yang-Xin Fu
Journal:  Cancer Lett       Date:  2015-10-19       Impact factor: 8.679

4.  Antiangiogenic therapy and immune checkpoint blockade go hand in hand.

Authors:  Luis Felipe Campesato; Taha Merghoub
Journal:  Ann Transl Med       Date:  2017-12

5.  Genetics of experimental allergic encephalomyelitis supports the role of T helper cells in multiple sclerosis pathogenesis.

Authors:  Elizabeth P Blankenhorn; Russell Butterfield; Laure K Case; Emma H Wall; Roxana del Rio; Sean A Diehl; Dimitry N Krementsov; Naresha Saligrama; Cory Teuscher
Journal:  Ann Neurol       Date:  2011-12       Impact factor: 10.422

6.  Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection.

Authors:  Yugang Wang; Ekaterina P Koroleva; Andrei A Kruglov; Dmitry V Kuprash; Sergei A Nedospasov; Yang-Xin Fu; Alexei V Tumanov
Journal:  Immunity       Date:  2010-03-11       Impact factor: 31.745

7.  Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade.

Authors:  Haidong Tang; Yang Wang; Lukasz K Chlewicki; Yuan Zhang; Jingya Guo; Wei Liang; Jieyi Wang; Xiaoxiao Wang; Yang-Xin Fu
Journal:  Cancer Cell       Date:  2016-03-14       Impact factor: 31.743

Review 8.  Mechanisms of costimulation.

Authors:  Arlene H Sharpe
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 9.  Programming CAR T cells to enhance anti-tumor efficacy through remodeling of the immune system.

Authors:  Xiaohui Wang; Zhiqiang Wu; Wei Qiu; Ping Chen; Xiang Xu; Weidong Han
Journal:  Front Med       Date:  2020-08-13       Impact factor: 4.592

10.  Shedding LIGHT (TNFSF14) on the tumor microenvironment of colorectal cancer liver metastases.

Authors:  Jian Zhong Qin; Vivek Upadhyay; Bellur Prabhakar; Ajay V Maker
Journal:  J Transl Med       Date:  2013-03-20       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.